This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Good morning everyone. We go ahead and get started with the next presentation. I’m very pleased to welcome management team from Hill-Rom. We have John Greisch and Mark Guinan; CEO and CFO, respectively, here this morning and as always like to keep it as interactive as possible. Andy Rieth is hiding in the audience. So, any of you guys who want to tap him for a question he is sitting right over here in front.
But John maybe we can sort of start off by giving us an update on how the business has progressed and if you put out the LRP just over a year May of 2011 you presented a long range plan and since that, I think business dynamics have not exactly played out. I think as most might have expected. Just frame pretty impressed. What’s changed in the macro environment over the past year and what have been through the surprises to the upside and the downside relative to what you laid out last May?
Yes, I think the rigorous change since then is probably Europe which I think is [two-fold]. Everybody in the med device world the uncertainty in the impact of austerity measures and spending on healthcare in Europe is certainly different than I think what we had anticipated going back 18 months when we began pulling the LRP together. I think as we came into this year, our expectations for Europe included decline in revenues in the low single-digit range which is what we have experienced and that certainly wasn’t part of our long range planning for Europe. So, in that timeframe I think Europe certainly would be at the top in the list of what’s changed.